Last reviewed · How we verify
NCT03405103: S2BS
Striving to be Strong: Self-management
NA trial testing Striving in Osteoporosis in 290 participants. Completed in 30 June 2016.
15 May 2016
Quick facts
| Lead sponsor | University of Wisconsin, Milwaukee |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 290 |
| Start date | 1 October 2012 |
| Primary completion | 15 May 2016 |
| Estimated completion | 30 June 2016 |
Drugs / interventions tested
- Striving
- Boning-Up
- Personal Choice
Conditions studied
- Osteoporosis — all drugs for Osteoporosis →
- Health Behavior — all drugs for Health Behavior →
Sponsor
University of Wisconsin, Milwaukee
Who can join
Adults 40 to 60, female only, with Osteoporosis or Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The vast majority of people want to be healthy and often make a change to be healthier. Change that is begun is seldom maintained. Osteoporosis is an example of one condition where people are encouraged to regularly engage in preventative health behaviors. This is a study testing a new approach to helping women engage in osteoporosis health behaviors. This new approach includes beliefs, self-regulating skills and abilities, and social facilitation delivered via a cell phone app. If effective, this approach could be tested with other health behaviors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of Osteoporosis Prevention Smartphone App.
Ryan P, Brown RL, Csuka ME, Papanek P. · · 2020 · cited 9× · PMID 31568199 · DOI 10.1097/nnr.0000000000000392
Verify or expand the search:
- PubMed search for NCT03405103
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoporosis
Currently open trials in the same condition.
- NCT07027306 — The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fract · recruiting
- NCT07367776 — Patient Education in Osteoporosis (RCT-PATOS) · NA · recruiting
- NCT06731608 — OsteoPorotic fracTure preventION System (OPTIONS) Research Study · NA · recruiting
- NCT07281586 — Step-down Therapy After Long-term Osteoporosis Treatment · Phase 4 · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
Other University of Wisconsin, Milwaukee trials
Trials by the same sponsor.
- NCT05736302 — Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water · recruiting
- NCT06054386 — Attention Bias Modification Training for Social Phobia (ABMSP) · NA · recruiting
- NCT05330780 — Breathing Room Intervention to Achieve Better Lung Health in Older Adults · NA · completed
- NCT05112562 — Attentional Bias Modification Training for E-cigarette Users · NA · unknown
- NCT04660708 — Manual Physical Therapy During Pregnancy on Post Partum Perineal Trauma and Pain · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03405103 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Milwaukee
- Last refreshed: 26 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03405103.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing